Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 14.40
-0.50 (-3.36%)
Feb 11, 2026, 11:13 AM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 105.18 million as of February 11, 2026. Its market cap has decreased by -59.73% in one year.
Market Cap
105.18M
Enterprise Value
77.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.40
Market Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 105.18M, an increase of 109.48%. That is a compound annual growth rate of 8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 105.18M | -24.75% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karolinska Development AB | 169.06M |
| Isofol Medical AB | 168.52M |
| IRLAB Therapeutics AB | 142.36M |
| Biovica International AB | 129.61M |
| Simris Group AB (PUBL) | 126.32M |
| Biosergen AB | 106.61M |
| Active Biotech AB | 101.22M |
| Alligator Bioscience AB | 96.21M |